Eficacia en términos de respuesta clínica según criterios RECIST del tratamiento de primera línea con capecitabina en monoterapia en una paciente con carcinoma epidermoide de vagina y metástasis pulmonares

literature data about chemotherapy of vaginal metastatic squamous cell carcinoma are limited because of the rare incidence of this kind of tumours. in addition, some patients evaluated in clinical practice, usually are not good candidates for standard treatments or clinical trials. this situation makes new treatments a good choice, unless patients meet the selection criteria to be included in a clinical trial. we present a case of lung metastatic vaginal carcinoma with partial response (recist criteria) after three cycles of capecitabine monotherapy.